"You decide and we provide."
Cart 0

Novartis advances with push on cancer and liver disease




reutersCOMPANYNEWS companyNews

ZURICH, April 18 (Reuters) - Novartis's push into oncology and liver disease, two of its treatment priorities, advanced on Monday as the Swiss drugmaker won a second U.S. breakthrough tag for its cancer gene therapy while striking a separate pact with Allergan.




Older Post Newer Post


Leave a comment

Please note, comments must be approved before they are published